PT  - JOURNAL ARTICLE
AU  - Hong, Yun Soo
AU  - Longchamps, Ryan J.
AU  - Zhao, Di
AU  - Castellani, Christina A.
AU  - Loehr, Laura R.
AU  - Chang, Patricia P.
AU  - Matsushita, Kunihiro
AU  - Grove, Megan L.
AU  - Boerwinkle, Eric
AU  - Arking, Dan E.
AU  - Guallar, Eliseo
TI  - Mitochondrial DNA copy number and incident heart failure: The Atherosclerosis Risk in Communities (ARIC) study
AID  - 10.1101/19012013
DP  - 2019 Jan 01
TA  - medRxiv
PG  - 19012013
4099  - http://medrxiv.org/content/early/2019/11/15/19012013.short
4100  - http://medrxiv.org/content/early/2019/11/15/19012013.full
AB  - Background The association between mitochondrial DNA-copy number (mtDNA-CN) and incident heart failure (HF) in the general population is unclear.Methods We examined the association between mtDNA-CN and the risk of incident HF among 10,802 participants free of HF at baseline from the Atherosclerosis Risk in Communities (ARIC) study, a large bi-racial population-based cohort. mtDNA-CN was estimated using probe intensities on the Affymetrix Genome-Wide Human single nucleotide polymorphisms Array 6.0. Incident HF events were identified through hospital discharge codes from 1987 until 2005 and through adjudication by the ARIC HF Classification Committee since 2005.Results During a median follow-up of 23.1 years, there were 2,227 incident HF events (incidence rate 10.3 per 1000 person-years). In fully adjusted models, the hazard ratios (95% confidence intervals) for HF comparing the 2nd through 5th quintiles of mtDNA-CN to the 1st quintile were 0.91 (0.80–1.04), 0.82 (0.72–0.93), 0.81 (0.71–0.92), and 0.74 (0.65–0.85), respectively (P for trend < 0.001). In stratified analyses, the associations between mtDNA-CN and HF were similar across examined subgroups. The inverse association between mtDNA-CN and incident HF was stronger in HF with reduced ejection fraction (HFrEF) than in HF with preserved ejection fraction (HFpEF).Conclusions In this prospective cohort, mtDNA-CN was inversely associated with the risk of incident HF suggesting that reduced levels of mtDNA-CN, a biomarker of mitochondrial dysfunction, could reflect early susceptibility to HF.Competing Interest StatementThe authors have declared no competing interest.Funding StatementUS National Institutes of Health grants (R01HL131573 to E.G., R.J.L., C.A.C., D.E.A.; and R01HL111267 to R.J.L., D.E.A.). The Atherosclerosis Risk in Communities study has been funded in whole or in part with Federal funds from the National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services (contract numbers HHSN268201700001I, HHSN268201700002I, HHSN268201700003I, HHSN268201700004I and HHSN268201700005I), R01HL087641, R01HL059367, R01HL086694; National Human Genome Research Institute contract U01HG004402; and National Institutes of Health contract HHSN268200625226C. Infrastructure was partly supported by Grant Number UL1RR025005, a component of the National Institutes of Health and NIH Roadmap for Medical Research.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe detailed policies for requesting and accessing the ARIC data can be found in the following website: https://sites.cscc.unc.edu/aric/distribution-agreements. It is also possible to obtain most ARIC data from BioLINCC, a repository maintained by the National Heart, Lung, and Blood Institute. The BioLINCC website (https://biolincc.nhlbi.nih.gov/) includes detailed information about the available data and the process to obtain such data.